Morepen Laboratories Ltd.
MOREPENLAB Share PricePharmaceuticals & Drugs
₹46.97
-0.5 (-1.1%)
As on November 7, 2025
Exchange Scrips: BSE500288NSEMOREPENLABISININE083A01026
Market Cap ₹ 2,577 Cr
P/E Ratio 21.81
Dividend Yield 0.21 %
Performance
Market performance
Open47.68
High47.68
Volumes10,79,019
Prev46.97
Low46.72
As on2025-11-07
Historical performance
1 Year High91.7
3 Year High100.9
5 Year High100.9
1 Year Low42
3 Year Low24
5 Year Low23.6
Fundamentals
Company Valuation
Market Cap (₹Cr)
2,577
Face Value (₹)
2
P/E Ratio
21.81
Dividend Yield
0.21 %
Investment Returns
1 Year
-44.5%
3 Years
62.8%
5 Years
70.8%
10 Years
127.5%
Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 47.67 | Bearish |
| 10-DMA | 48.1 | Bearish |
| 20-DMA | 48.37 | Bearish |
| 50-DMA | 49.57 | Bearish |
| 100-DMA | 53.94 | Bearish |
| 200-DMA | 55.52 | Bearish |
Shareholding Pattern
| Field | Sep-2025 | Jun-2025 | Mar-2025 | Dec-2024 | Sep-2024 |
|---|---|---|---|---|---|
| Promoters | 35 | 35 | 35 | 35 | 35 |
| Foreign Investors | --- | --- | --- | --- | --- |
| Domestic Investors | 35 | 35 | 35 | 35 | 35 |
| Public Investors | 461818 | 461145 | 468825 | 448326 | 430894 |
| Government | 1 | 1 | 1 | 1 | 1 |
Financials
Below figures are in Rs. Crores
Balance Sheet
Below figures are in Rs. Crores
Cash Flow
Below figures are in Rs. Crores
0%
Negative
Neutral
Positive
- The stock has a PE ratio of 21.81.
- 3Y Stock Price CAGR of the stock is 18.2.
- The stock has a beta of 1.9.
- In the last financial year, the company had an EBITDA of ₹1924 Million.
- The company generated revenue of ₹18116 Million in the previous financial year.
Morepen Laboratories Ltd.
46.97-0.5 (-1.1%)
₹
Investment Amount: ₹ 1000000
Current Value: ₹ 563594.9
No. of Shares: 11999 (Approx)
Performance:-43.6%
P/L: ₹-436405.1
Top Gainers
Top Losers
| Symbol | Change% |
|---|---|
| BLISSGVS | 127.9(-16%) |
| SILLYMONKS | 23(-12%) |
| RSSOFTWARE | 57.21(-10%) |
| SAATVIKGL | 490.25(-9%) |
| VENKEYS | 1391.6(-9%) |
| AMBER | 7227(-8%) |
| LATENTVIEW | 436.55(-7%) |
| DCAL | 248.85(-7%) |
Peer Comparison
Get Your Portfolio Reviewed
